Results 161 to 170 of about 3,606,010 (253)
In vivo CAR cell therapy: from bench to bedside. [PDF]
Xu J, Chen Z, Su L, Ren A, Mei H.
europepmc +1 more source
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
E. A. Shulenina +2 more
openalex +2 more sources
Microfluidics for cell therapy and manufacturing in oncology and regenerative medicine.
Duncan JL, Arroyo JP, Davalos RV.
europepmc +1 more source
CD30+ T-cell lymphoma following Chimeric Antigen Receptor T-cell therapy (CART-cell therapy): Diagnostic uncertainty in a postimmunotherapy setting. [PDF]
McClanahan M, Stokes M.
europepmc +1 more source
Chimeric Antigen Receptor T-Cell Therapy: More Than an Anti-Cancer Drug. [PDF]
Schenk HCM +8 more
europepmc +1 more source
Editorial: Achilles heel of CAR T-cell therapy. [PDF]
Chiriva-Internati M, Grizzi F.
europepmc +1 more source
Ex Vivo Gene and Cell Therapy in Hematopoietic Stem Cells. [PDF]
Petrova IO, Smirnikhina SA.
europepmc +1 more source
Bioengineering of Periodontal Tissues: Cell Therapy and Biomaterials Application. [PDF]
Norahan MH +7 more
europepmc +1 more source

